This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Microcrystalline cellulose
- DrugBank Accession Number
- DB14158
- Background
A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
- Type
- Small Molecule
- Groups
- Approved, Experimental, Investigational
- Synonyms
- Cellulose
- Cellulose crystalline
- Cellulose powder
- Cellulose regenerated
- Cellulose, microcrystalline
- Cellulose, powder
- Cellulose, powdered
- Hydroxycellulose
- Powdered cellulose
- Pyrocellulose
- Rayon
- External IDs
- CP-305
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Cellzyme Secret Therapy 3845 Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL) Cream Topical PHARMACAL-INTERNATIONAL. CO., LTD 2017-08-16 Not applicable US 
Cellzyme Secret Therapy 3845 Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL) Cream Topical PHARMACAL-INTERNATIONAL. CO., LTD 2017-08-16 Not applicable US METADONA CLORHIDRATO 40 MG TABLETA Microcrystalline cellulose (204 mg) + Lactose (342 mg) + Magnesium stearate (18 mg) + Methadone hydrochloride (40 mg) + Silicon dioxide (12 mg) Tablet Oral BLISTECO S.A.S. 2018-06-22 Not applicable Colombia 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- BX81F82EWG
- CAS number
- 9004-34-6
References
- General References
- Not Available
- External Links
- 2221
- Wikipedia
- Microcrystalline_cellulose
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Basic Science Chemoreceptor Apnea / Hypoxia / Respiration; Sleep Disorder / Sleep Disordered Breathing (SDB) 1 4 Completed Basic Science Type 2 Diabetes Mellitus 1 4 Completed Health Services Research Sedation / Surgery 1 4 Completed Other Cardiovascular Disease (CVD) 1 4 Completed Prevention Inflammation / Obesity / Resistance, Insulin 1 4 Completed Treatment Critically Ill Patients / Shock 1 4 Completed Treatment Irritable Bowel Syndrome (IBS) 1 4 Completed Treatment Obesity 1 4 Completed Treatment Schizophrenia 1 4 Completed Treatment Smoking Addiction 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Topical Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Drug created at June 29, 2018 15:08 / Updated at September 28, 2021 21:54